Search

Search Constraints

You searched for: Author/Creator Torrado, R.

Search Results

1. Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate‐to‐severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm. (6th June 2017)

2. Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. (15th July 2013)

3. Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry. (12th April 2017)

4. Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry. (31st March 2014)

5. Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry. (3rd September 2014)

6. Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis. (22nd June 2016)